In this model, an androgen receptor (AR)-positive and androgen-dependent (AD) mouse prostate cancer cell line, Myc-CaP, which was isolated from a c-Myc transgenic mouse prostate cancer [13], was employed. This evidence concerns the gene MYC and prostate cancer.